Nucleic acid molecules and multimeric proteins capable of binding vascular endothelial growth factor (VEGF). VEGF mini-traps are disclosed which are therapeutically useful for treating VEGF-associated conditions and diseases, and are specifically designed for local administration to specific organs, tissues, and/or cells.


< Vascular anchoring device

< Methods and apparatus for regulating the flow of matter through body tubing

> Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins

> Treatment of diabetes with synthetic beta cells

~ 00281